EastWest Bioscience Manufactures HempBeauti Shampoo and Conditioner under the Company’s ChanvreHemp Body Care Brand

VANCOUVER, BC / February 13, 2019 / EastWest Bioscience (the “Company” or “EastWest”) (TSX.V: EAST) announces the manufacturing of the first two products of its newest line of hemp-based products being introduced in 2019. The Company’s HempBeauti Shampoo and Conditioner is the first of a series of premium ultra-clean body care products under the ChanvreHemp brand line. HempBeauti Shampoo and Conditioner are due to be in stores late April or early May 2019.

“The Company is looking forward to the launch its newest line of body care products,” says Rodney Gelineau, CEO of EastWest Bioscience. “We’re starting with hair care, because it’s something everyone uses, and customers have been asking for it.”

“ChanvreHemp products have been formulated with one of the cleanest ingredients lists on the market. They are being manufactured to exacting standards by one of North America’s most respected natural products formulators and manufacturers. The new HempBeauti hair products will contain a generous amount of hemp oil well-known for its healthy, luxurious benefits to hair and skin.”

“We’re excited to get these first products to the market,” continues Gelineau. “The long-term strategy for ChanvreHemp is to develop innovative hemp-based body care products meant to pamper the body, mind and souls of health-conscious consumers of all ages and walks of life.”

The Company is moving to penetrate several categories within the retail store environment. By increasing exposure into multiple categories, it increases the potential for getting our hemp based products into the consumers shopping basket. Expanding the EastWest brand increases brand recognition and getting truly great hemp products into consumers’ homes will just instill and increase brand loyalty.

“This clean and unique shampoo and conditioner are just the first in a series of products we’ll be introducing to the Health and Beauty Care space.” says Fanika Jovanovic Perika, Global Business Development Lead at EastWest Bioscience. “Creating and introducing clean natural products, across multiple categories within the retail footprint, will continue to be part of the long-term strategy of product development for the company. Consumers are looking for more natural products for themselves and their family. What they put on their bodies is as important as what they put in their bodies. We are very excited about this initial launch into the category.”

About EastWest Bioscience Group

EastWest Bioscience is a seed-to-sale organization that offers nutraceutical manufacturing and premium hemp-based consumer goods and sells them through national distributors such as Mondou and Purity Distributors, as well as EastWest’s own 27 Sangster’s branded retail stores, one of Canada’s oldest and most respected natural health chains. Since it was founded in 2016, EastWest continues to grow as a high-quality producer, manufacturer and distributor of multiple lines of premium hemp products. EastWest is strategically positioned in mainstream consumer markets with wholistic natural products and has developed distribution channels into mainstream stores and markets in Canada. The Company has a Health Canada licensed, GMP (Good Manufacturing Practices) certified manufacturing facility and produces premium brands offering natural products for a preventive care lifestyle. EastWest consumer product lines are divided into four distinct brands: 1) Natural Advancement – natural biopharmaceutical health supplements; 2) Earth’s Menu – all-natural hemp superfoods; 3) Natural Pet Science – pet food and pet supplements; and 4) ChanvreHemp – all-natural health and beauty products. The organization will continue to focus on ongoing development of innovative, hemp-based consumer products through advanced science with clean, natural ingredients to complement its current product offerings.

ON BEHALF OF THE BOARD OF DIRECTORS

EASTWEST BIOSCIENCE GROUP

“Rodney Gelineau” 
Co-Founder, Chief Executive Officer and Director

For further information, please visit www.eastwestbioscience.com or contact EastWest Bioscience Investor Relations at 1-647-394-7383 or email us at investors@eastwestscience.com.

NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news release includes certain “forward-looking statements” under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to the terms and conditions of the Acquisition. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties; and delay or failure to receive board, shareholder or regulatory approvals. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Corporation disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.